The global colposcopes market size was valued at $470 million in 2018, and is projected to reach $661 million by 2026, registering a CAGR of 4.3%.
Colposcopy is a procedure to closely examine cervix, vagina, and vulva through a special magnifying device called a colposcope. Different forms of colposcopes such as portable, handheld, and stationary are available in the colposcopes market, which are used to diagnose cervical cancer, genital warts, vaginal cancer, and vulvar cancer.
Increase in prevalence of cervical cancer, rise in awareness among people toward early detection of the disease, and availability of innovative products are the major factors that drive the growth of the colposcopes market. In addition, colposcopy is a painless, non-invasive procedure, with no blood loss; and is cost efficient, which further influences their demand globally. In addition, rise in demand for colposcopes among developing countries, and surge in uptake of colposcopes for screening of gynecological disorders are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for the growth of the market during the forecast period. However, complications associated with the use are anticipated to hinder the colposcope market growth.
Colposcopes Market Segmentation
The colposcopes market is segmented into product type, application, end user, and region. By product type, it is categorized into portable, handheld, and stationary. Depending on application, it is classified into cervical cancer screening and physical examinations. According to end user, it is classified into diagnostic centers, hospitals, and clinics. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment Review
By product type, presently, the portable segment dominates the global market, and is anticipated to continue this trend over the forecast period, owing to ease of sample handling, portability, screening convenience, and higher adoption of portable colposcopes in hospitals and gynecological clinics. The Cooper Companies Inc., McKesson Corporation, Karl Kaps Gmbh & Co. Kg., and Carl Zeiss AG are the key players involved in the portable colposcope market. Leisegang Colposcope, ZoomStar, ZoomScope, Colposcope KSK 150 FC, McKesson LUMEON and others are major brands available in market. The handheld colposcope segment is expected to show fastest market growth during the forecast period majorly due to technological advancements and ease of handling. These are smaller than portable analyzers and thus have emerged as a more convenient option for screening. Handheld analyzers have enhanced test efficiency and productivity by reducing time and labor required to collect, process, and report results.
On the basis of application, the cervical cancer screening segment accounted for majority of the colposcopes market share in 2018, owing to surge in number of target population and growing awareness for cervical cancer screening among people. In addition, technological advancements in colposcopes, and availability of technologically advanced screening tools majorly drive the market growth for this segment. For instance, according to the World Health Organization, cervical cancer is the fourth most frequent cancer in women, with 570,000 new cases in 2018, representing around 6.6% of all female cancers.
Asia-Pacific Colposcopes Market
Asia-Pacific presents lucrative opportunities for key players operating in the colposcopes market. Growth in awareness about early screening of diseases and rise in adoption of colposcopes products is expected to drive market growth in Asia-Pacific. Moreover, improvements in healthcare infrastructure, rise in number of hospitals & diagnostic centers, equipped with advanced medical facilities also contributes to the market growth. Some other factors such as surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries are expected to drive the growth of the colposcopes market in Asia-Pacific.
The key players profiled in this report include Carl Zeiss AG, Danaher Corporation (Leica Microsystem), Ecleris S.R.L., Gynex Corporation, Karl Kaps Gmbh & Co. Kg, Kernel Medical Equipment Co., Ltd., McKesson Corporation, Medgyn Products Inc., Seiler Instrument & Mfg. Co. Inc., and The Cooper Companies, Inc. (Wallach Surgical Devices)